penicillamine

Key facts

INN

penicillamine

Brand

LUXZYLA

Route

ORAL

Formulation

CAPSULE

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12331026

Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12208167

Coated tablets for pH-dependent release of benzgalantamine

Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12188005

NK cells with an increased antibody-dependent cellular toxicity (ADCC) against t

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12156877

Methods of treating conditions related to a thiamine deficiency, a thiamine-depe

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12036231

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent sign

Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11945822

Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor

Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11897932

Receptors for ligand-dependent transcriptional regulation

Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11801234

Methods of treating APOL-1 dependent focal segmental glomerulosclerosis

Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is penicillamine?

penicillamine (LUXZYLA), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for penicillamine?

LUXZYLA is a marketed brand name for penicillamine. Check FDA Drugs@FDA for the current US label holder.